Overview

Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma

Status:
Completed
Trial end date:
2017-05-15
Target enrollment:
Participant gender:
Summary
To assess the efficacy of an Angiotensin-II inhibitor (Losartan) to reduce peritumoral edema in newly diagnosed glioblastoma patients.
Phase:
Phase 3
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborator:
ANOCEF (french association of neuro-oncologists)
Treatments:
Angiotensin II
Angiotensin Receptor Antagonists
Angiotensinogen
Losartan
Temozolomide